nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabergoline—HTR1D—meninx—sarcoma	0.0724	0.18	CbGeAlD
Cabergoline—HTR1B—dura mater—sarcoma	0.0688	0.171	CbGeAlD
Cabergoline—HTR1D—dura mater—sarcoma	0.0666	0.165	CbGeAlD
Cabergoline—HTR7—pulmonary artery—sarcoma	0.0226	0.0562	CbGeAlD
Cabergoline—HTR2A—pulmonary artery—sarcoma	0.0141	0.0351	CbGeAlD
Cabergoline—HTR2A—hindlimb—sarcoma	0.00854	0.0212	CbGeAlD
Cabergoline—HTR2A—appendage—sarcoma	0.00733	0.0182	CbGeAlD
Cabergoline—DRD5—hematopoietic system—sarcoma	0.00729	0.0181	CbGeAlD
Cabergoline—HTR7—endothelium—sarcoma	0.00709	0.0176	CbGeAlD
Cabergoline—DRD4—testis—sarcoma	0.00607	0.0151	CbGeAlD
Cabergoline—DRD5—lymphoid tissue—sarcoma	0.00514	0.0127	CbGeAlD
Cabergoline—HTR2B—myometrium—sarcoma	0.00474	0.0118	CbGeAlD
Cabergoline—HTR2A—endothelium—sarcoma	0.00442	0.011	CbGeAlD
Cabergoline—HTR1D—connective tissue—sarcoma	0.00421	0.0105	CbGeAlD
Cabergoline—ADRB1—connective tissue—sarcoma	0.00409	0.0102	CbGeAlD
Cabergoline—ADRA2C—myometrium—sarcoma	0.00373	0.00926	CbGeAlD
Cabergoline—HTR1A—hematopoietic system—sarcoma	0.00364	0.00905	CbGeAlD
Cabergoline—HTR2B—smooth muscle tissue—sarcoma	0.00358	0.00889	CbGeAlD
Cabergoline—HTR2B—skin of body—sarcoma	0.00354	0.00878	CbGeAlD
Cabergoline—HTR7—hematopoietic system—sarcoma	0.00348	0.00865	CbGeAlD
Cabergoline—ADRA2C—seminal vesicle—sarcoma	0.00337	0.00836	CbGeAlD
Cabergoline—ADRA1A—hematopoietic system—sarcoma	0.00336	0.00834	CbGeAlD
Cabergoline—HTR7—connective tissue—sarcoma	0.00335	0.00832	CbGeAlD
Cabergoline—ADRB1—cardiac atrium—sarcoma	0.00323	0.00801	CbGeAlD
Cabergoline—HTR2B—uterus—sarcoma	0.00307	0.00763	CbGeAlD
Cabergoline—HTR7—smooth muscle tissue—sarcoma	0.00307	0.00762	CbGeAlD
Cabergoline—ADRA2A—myometrium—sarcoma	0.00297	0.00739	CbGeAlD
Cabergoline—HTR2B—tendon—sarcoma	0.00269	0.00668	CbGeAlD
Cabergoline—ADRA2A—seminal vesicle—sarcoma	0.00269	0.00667	CbGeAlD
Cabergoline—ADRA2A—hematopoietic system—sarcoma	0.00255	0.00634	CbGeAlD
Cabergoline—ADRA2A—connective tissue—sarcoma	0.00246	0.00611	CbGeAlD
Cabergoline—HTR2A—embryo—sarcoma	0.00243	0.00604	CbGeAlD
Cabergoline—ADRA2C—cardiac atrium—sarcoma	0.00243	0.00603	CbGeAlD
Cabergoline—ADRA2C—uterus—sarcoma	0.00242	0.006	CbGeAlD
Cabergoline—ADRA1A—lymphoid tissue—sarcoma	0.00237	0.00587	CbGeAlD
Cabergoline—HTR7—tendon—sarcoma	0.00231	0.00572	CbGeAlD
Cabergoline—HTR2A—hematopoietic system—sarcoma	0.00217	0.00539	CbGeAlD
Cabergoline—ADRA2C—tendon—sarcoma	0.00212	0.00526	CbGeAlD
Cabergoline—HTR2A—connective tissue—sarcoma	0.00209	0.00519	CbGeAlD
Cabergoline—CYP3A4—hematopoietic system—sarcoma	0.00201	0.00499	CbGeAlD
Cabergoline—ADRA2A—cardiac atrium—sarcoma	0.00194	0.00481	CbGeAlD
Cabergoline—ADRA2A—uterus—sarcoma	0.00193	0.00479	CbGeAlD
Cabergoline—HTR2A—smooth muscle tissue—sarcoma	0.00191	0.00475	CbGeAlD
Cabergoline—HTR7—testis—sarcoma	0.00191	0.00474	CbGeAlD
Cabergoline—Somnolence—Thiotepa—sarcoma	0.00181	0.00303	CcSEcCtD
Cabergoline—DRD2—testis—sarcoma	0.0018	0.00448	CbGeAlD
Cabergoline—HTR7—liver—sarcoma	0.0018	0.00448	CbGeAlD
Cabergoline—Oedema—Vincristine—sarcoma	0.0018	0.00302	CcSEcCtD
Cabergoline—Dyspepsia—Thiotepa—sarcoma	0.00179	0.003	CcSEcCtD
Cabergoline—Hot flush—Epirubicin—sarcoma	0.00178	0.00298	CcSEcCtD
Cabergoline—Confusional state—Mitoxantrone—sarcoma	0.00177	0.00296	CcSEcCtD
Cabergoline—Decreased appetite—Thiotepa—sarcoma	0.00177	0.00296	CcSEcCtD
Cabergoline—Menopausal symptoms—Epirubicin—sarcoma	0.00177	0.00296	CcSEcCtD
Cabergoline—Hepatic function abnormal—Doxorubicin—sarcoma	0.00176	0.00295	CcSEcCtD
Cabergoline—Oedema—Mitoxantrone—sarcoma	0.00176	0.00294	CcSEcCtD
Cabergoline—Decreased appetite—Dactinomycin—sarcoma	0.00175	0.00294	CcSEcCtD
Cabergoline—ADRA2C—testis—sarcoma	0.00175	0.00435	CbGeAlD
Cabergoline—Fatigue—Thiotepa—sarcoma	0.00175	0.00294	CcSEcCtD
Cabergoline—Hyperhidrosis—Vincristine—sarcoma	0.00174	0.00292	CcSEcCtD
Cabergoline—ADRA1A—liver—sarcoma	0.00174	0.00432	CbGeAlD
Cabergoline—Fatigue—Dactinomycin—sarcoma	0.00174	0.00291	CcSEcCtD
Cabergoline—Pain—Thiotepa—sarcoma	0.00174	0.00291	CcSEcCtD
Cabergoline—Constipation—Thiotepa—sarcoma	0.00174	0.00291	CcSEcCtD
Cabergoline—Back pain—Etoposide—sarcoma	0.00173	0.0029	CcSEcCtD
Cabergoline—Shock—Mitoxantrone—sarcoma	0.00173	0.00289	CcSEcCtD
Cabergoline—Pain—Dactinomycin—sarcoma	0.00173	0.00289	CcSEcCtD
Cabergoline—Muscle spasms—Etoposide—sarcoma	0.00172	0.00288	CcSEcCtD
Cabergoline—Anorexia—Vincristine—sarcoma	0.00172	0.00288	CcSEcCtD
Cabergoline—Cardiac failure—Epirubicin—sarcoma	0.00171	0.00286	CcSEcCtD
Cabergoline—Hyperhidrosis—Mitoxantrone—sarcoma	0.0017	0.00284	CcSEcCtD
Cabergoline—ADRA2A—tendon—sarcoma	0.00169	0.0042	CbGeAlD
Cabergoline—Hypotension—Vincristine—sarcoma	0.00168	0.00282	CcSEcCtD
Cabergoline—Feeling abnormal—Thiotepa—sarcoma	0.00168	0.00281	CcSEcCtD
Cabergoline—Anorexia—Mitoxantrone—sarcoma	0.00167	0.0028	CcSEcCtD
Cabergoline—Osteoarthritis—Epirubicin—sarcoma	0.00167	0.00279	CcSEcCtD
Cabergoline—Feeling abnormal—Dactinomycin—sarcoma	0.00166	0.00278	CcSEcCtD
Cabergoline—Gastrointestinal pain—Thiotepa—sarcoma	0.00166	0.00278	CcSEcCtD
Cabergoline—Ill-defined disorder—Etoposide—sarcoma	0.00166	0.00278	CcSEcCtD
Cabergoline—ADRA2C—liver—sarcoma	0.00166	0.00412	CbGeAlD
Cabergoline—Gastrointestinal pain—Dactinomycin—sarcoma	0.00165	0.00276	CcSEcCtD
Cabergoline—Hot flush—Doxorubicin—sarcoma	0.00165	0.00276	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Vincristine—sarcoma	0.00164	0.00275	CcSEcCtD
Cabergoline—Hypotension—Mitoxantrone—sarcoma	0.00164	0.00275	CcSEcCtD
Cabergoline—Menopausal symptoms—Doxorubicin—sarcoma	0.00163	0.00274	CcSEcCtD
Cabergoline—Insomnia—Vincristine—sarcoma	0.00163	0.00273	CcSEcCtD
Cabergoline—Paraesthesia—Vincristine—sarcoma	0.00162	0.00271	CcSEcCtD
Cabergoline—HTR2B—lymph node—sarcoma	0.00162	0.00401	CbGeAlD
Cabergoline—Malaise—Etoposide—sarcoma	0.00161	0.0027	CcSEcCtD
Cabergoline—Face oedema—Epirubicin—sarcoma	0.00161	0.00269	CcSEcCtD
Cabergoline—Vertigo—Etoposide—sarcoma	0.00161	0.00269	CcSEcCtD
Cabergoline—Abdominal pain—Thiotepa—sarcoma	0.00161	0.00269	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.0016	0.00268	CcSEcCtD
Cabergoline—Abdominal pain—Dactinomycin—sarcoma	0.0016	0.00267	CcSEcCtD
Cabergoline—Cardiac failure—Doxorubicin—sarcoma	0.00158	0.00264	CcSEcCtD
Cabergoline—Paraesthesia—Mitoxantrone—sarcoma	0.00158	0.00264	CcSEcCtD
Cabergoline—Loss of consciousness—Etoposide—sarcoma	0.00157	0.00263	CcSEcCtD
Cabergoline—Decreased appetite—Vincristine—sarcoma	0.00157	0.00262	CcSEcCtD
Cabergoline—Dyspnoea—Mitoxantrone—sarcoma	0.00157	0.00262	CcSEcCtD
Cabergoline—Somnolence—Mitoxantrone—sarcoma	0.00156	0.00261	CcSEcCtD
Cabergoline—Blood creatinine increased—Epirubicin—sarcoma	0.00156	0.00261	CcSEcCtD
Cabergoline—Fatigue—Vincristine—sarcoma	0.00155	0.0026	CcSEcCtD
Cabergoline—Dyspepsia—Mitoxantrone—sarcoma	0.00155	0.00259	CcSEcCtD
Cabergoline—Hypertension—Etoposide—sarcoma	0.00155	0.00259	CcSEcCtD
Cabergoline—Constipation—Vincristine—sarcoma	0.00154	0.00258	CcSEcCtD
Cabergoline—Pain—Vincristine—sarcoma	0.00154	0.00258	CcSEcCtD
Cabergoline—Osteoarthritis—Doxorubicin—sarcoma	0.00154	0.00258	CcSEcCtD
Cabergoline—Liver function test abnormal—Epirubicin—sarcoma	0.00154	0.00258	CcSEcCtD
Cabergoline—Decreased appetite—Mitoxantrone—sarcoma	0.00153	0.00256	CcSEcCtD
Cabergoline—Orthostatic hypotension—Epirubicin—sarcoma	0.00152	0.00255	CcSEcCtD
Cabergoline—Abdominal pain upper—Epirubicin—sarcoma	0.00152	0.00255	CcSEcCtD
Cabergoline—Fatigue—Mitoxantrone—sarcoma	0.00151	0.00254	CcSEcCtD
Cabergoline—Discomfort—Etoposide—sarcoma	0.00151	0.00252	CcSEcCtD
Cabergoline—Constipation—Mitoxantrone—sarcoma	0.0015	0.00251	CcSEcCtD
Cabergoline—Pain—Mitoxantrone—sarcoma	0.0015	0.00251	CcSEcCtD
Cabergoline—Hypersensitivity—Thiotepa—sarcoma	0.0015	0.00251	CcSEcCtD
Cabergoline—Face oedema—Doxorubicin—sarcoma	0.00149	0.00249	CcSEcCtD
Cabergoline—Hypersensitivity—Dactinomycin—sarcoma	0.00149	0.00249	CcSEcCtD
Cabergoline—Gastrointestinal pain—Vincristine—sarcoma	0.00147	0.00247	CcSEcCtD
Cabergoline—Gastritis—Epirubicin—sarcoma	0.00147	0.00247	CcSEcCtD
Cabergoline—Confusional state—Etoposide—sarcoma	0.00147	0.00247	CcSEcCtD
Cabergoline—Asthenia—Thiotepa—sarcoma	0.00146	0.00244	CcSEcCtD
Cabergoline—Asthenia—Dactinomycin—sarcoma	0.00145	0.00242	CcSEcCtD
Cabergoline—Feeling abnormal—Mitoxantrone—sarcoma	0.00145	0.00242	CcSEcCtD
Cabergoline—Blood creatinine increased—Doxorubicin—sarcoma	0.00144	0.00242	CcSEcCtD
Cabergoline—Influenza—Epirubicin—sarcoma	0.00144	0.00241	CcSEcCtD
Cabergoline—Pruritus—Thiotepa—sarcoma	0.00144	0.00241	CcSEcCtD
Cabergoline—HTR2A—tendon—sarcoma	0.00144	0.00357	CbGeAlD
Cabergoline—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00144	0.0024	CcSEcCtD
Cabergoline—Abdominal pain—Vincristine—sarcoma	0.00143	0.00239	CcSEcCtD
Cabergoline—Liver function test abnormal—Doxorubicin—sarcoma	0.00142	0.00238	CcSEcCtD
Cabergoline—Hyperhidrosis—Etoposide—sarcoma	0.00141	0.00236	CcSEcCtD
Cabergoline—Abdominal pain upper—Doxorubicin—sarcoma	0.00141	0.00236	CcSEcCtD
Cabergoline—Orthostatic hypotension—Doxorubicin—sarcoma	0.00141	0.00236	CcSEcCtD
Cabergoline—ADRA2A—testis—sarcoma	0.0014	0.00347	CbGeAlD
Cabergoline—Anorexia—Etoposide—sarcoma	0.00139	0.00233	CcSEcCtD
Cabergoline—Diarrhoea—Thiotepa—sarcoma	0.00139	0.00233	CcSEcCtD
Cabergoline—Abdominal pain—Mitoxantrone—sarcoma	0.00139	0.00232	CcSEcCtD
Cabergoline—Bronchitis—Epirubicin—sarcoma	0.00138	0.00232	CcSEcCtD
Cabergoline—Diarrhoea—Dactinomycin—sarcoma	0.00138	0.00231	CcSEcCtD
Cabergoline—Hypotension—Etoposide—sarcoma	0.00136	0.00229	CcSEcCtD
Cabergoline—Gastritis—Doxorubicin—sarcoma	0.00136	0.00228	CcSEcCtD
Cabergoline—Dizziness—Thiotepa—sarcoma	0.00134	0.00225	CcSEcCtD
Cabergoline—Upper respiratory tract infection—Epirubicin—sarcoma	0.00134	0.00224	CcSEcCtD
Cabergoline—Influenza—Doxorubicin—sarcoma	0.00133	0.00223	CcSEcCtD
Cabergoline—Hypersensitivity—Vincristine—sarcoma	0.00133	0.00222	CcSEcCtD
Cabergoline—Paraesthesia—Etoposide—sarcoma	0.00131	0.0022	CcSEcCtD
Cabergoline—Weight increased—Epirubicin—sarcoma	0.00131	0.00219	CcSEcCtD
Cabergoline—Weight decreased—Epirubicin—sarcoma	0.0013	0.00218	CcSEcCtD
Cabergoline—Dyspnoea—Etoposide—sarcoma	0.0013	0.00218	CcSEcCtD
Cabergoline—Somnolence—Etoposide—sarcoma	0.0013	0.00217	CcSEcCtD
Cabergoline—Hypersensitivity—Mitoxantrone—sarcoma	0.00129	0.00217	CcSEcCtD
Cabergoline—Asthenia—Vincristine—sarcoma	0.00129	0.00217	CcSEcCtD
Cabergoline—Vomiting—Thiotepa—sarcoma	0.00129	0.00216	CcSEcCtD
Cabergoline—Pneumonia—Epirubicin—sarcoma	0.00129	0.00216	CcSEcCtD
Cabergoline—Vomiting—Dactinomycin—sarcoma	0.00128	0.00215	CcSEcCtD
Cabergoline—Rash—Thiotepa—sarcoma	0.00128	0.00215	CcSEcCtD
Cabergoline—Bronchitis—Doxorubicin—sarcoma	0.00128	0.00215	CcSEcCtD
Cabergoline—Dermatitis—Thiotepa—sarcoma	0.00128	0.00214	CcSEcCtD
Cabergoline—Headache—Thiotepa—sarcoma	0.00127	0.00213	CcSEcCtD
Cabergoline—Rash—Dactinomycin—sarcoma	0.00127	0.00213	CcSEcCtD
Cabergoline—ADRA2C—lymph node—sarcoma	0.00127	0.00316	CbGeAlD
Cabergoline—Decreased appetite—Etoposide—sarcoma	0.00127	0.00213	CcSEcCtD
Cabergoline—Asthenia—Mitoxantrone—sarcoma	0.00126	0.00211	CcSEcCtD
Cabergoline—Fatigue—Etoposide—sarcoma	0.00126	0.00211	CcSEcCtD
Cabergoline—Pain—Etoposide—sarcoma	0.00125	0.00209	CcSEcCtD
Cabergoline—Constipation—Etoposide—sarcoma	0.00125	0.00209	CcSEcCtD
Cabergoline—Urinary tract infection—Epirubicin—sarcoma	0.00125	0.00209	CcSEcCtD
Cabergoline—Upper respiratory tract infection—Doxorubicin—sarcoma	0.00124	0.00207	CcSEcCtD
Cabergoline—Diarrhoea—Vincristine—sarcoma	0.00123	0.00207	CcSEcCtD
Cabergoline—Weight increased—Doxorubicin—sarcoma	0.00121	0.00203	CcSEcCtD
Cabergoline—Epistaxis—Epirubicin—sarcoma	0.00121	0.00203	CcSEcCtD
Cabergoline—Nausea—Thiotepa—sarcoma	0.00121	0.00202	CcSEcCtD
Cabergoline—Weight decreased—Doxorubicin—sarcoma	0.00121	0.00202	CcSEcCtD
Cabergoline—Feeling abnormal—Etoposide—sarcoma	0.0012	0.00202	CcSEcCtD
Cabergoline—Diarrhoea—Mitoxantrone—sarcoma	0.0012	0.00201	CcSEcCtD
Cabergoline—Nausea—Dactinomycin—sarcoma	0.0012	0.00201	CcSEcCtD
Cabergoline—Pneumonia—Doxorubicin—sarcoma	0.00119	0.002	CcSEcCtD
Cabergoline—Gastrointestinal pain—Etoposide—sarcoma	0.00119	0.002	CcSEcCtD
Cabergoline—Dizziness—Vincristine—sarcoma	0.00119	0.002	CcSEcCtD
Cabergoline—HTR2A—testis—sarcoma	0.00119	0.00295	CbGeAlD
Cabergoline—Rhinitis—Epirubicin—sarcoma	0.00116	0.00193	CcSEcCtD
Cabergoline—Abdominal pain—Etoposide—sarcoma	0.00115	0.00193	CcSEcCtD
Cabergoline—Urinary tract infection—Doxorubicin—sarcoma	0.00115	0.00193	CcSEcCtD
Cabergoline—Vomiting—Vincristine—sarcoma	0.00115	0.00192	CcSEcCtD
Cabergoline—Rash—Vincristine—sarcoma	0.00114	0.0019	CcSEcCtD
Cabergoline—Dermatitis—Vincristine—sarcoma	0.00114	0.0019	CcSEcCtD
Cabergoline—Oedema peripheral—Epirubicin—sarcoma	0.00114	0.0019	CcSEcCtD
Cabergoline—Headache—Vincristine—sarcoma	0.00113	0.00189	CcSEcCtD
Cabergoline—HTR2A—liver—sarcoma	0.00113	0.00279	CbGeAlD
Cabergoline—Epistaxis—Doxorubicin—sarcoma	0.00112	0.00188	CcSEcCtD
Cabergoline—Vomiting—Mitoxantrone—sarcoma	0.00112	0.00187	CcSEcCtD
Cabergoline—Visual impairment—Epirubicin—sarcoma	0.00111	0.00186	CcSEcCtD
Cabergoline—Rash—Mitoxantrone—sarcoma	0.00111	0.00185	CcSEcCtD
Cabergoline—Dermatitis—Mitoxantrone—sarcoma	0.00111	0.00185	CcSEcCtD
Cabergoline—Headache—Mitoxantrone—sarcoma	0.0011	0.00184	CcSEcCtD
Cabergoline—Hypersensitivity—Etoposide—sarcoma	0.00108	0.0018	CcSEcCtD
Cabergoline—Nausea—Vincristine—sarcoma	0.00107	0.00179	CcSEcCtD
Cabergoline—Cardiac disorder—Epirubicin—sarcoma	0.00107	0.00179	CcSEcCtD
Cabergoline—Rhinitis—Doxorubicin—sarcoma	0.00107	0.00179	CcSEcCtD
Cabergoline—Oedema peripheral—Doxorubicin—sarcoma	0.00105	0.00176	CcSEcCtD
Cabergoline—Asthenia—Etoposide—sarcoma	0.00105	0.00175	CcSEcCtD
Cabergoline—Nausea—Mitoxantrone—sarcoma	0.00104	0.00175	CcSEcCtD
Cabergoline—CYP3A4—liver—sarcoma	0.00104	0.00259	CbGeAlD
Cabergoline—Pruritus—Etoposide—sarcoma	0.00103	0.00173	CcSEcCtD
Cabergoline—Arrhythmia—Epirubicin—sarcoma	0.00103	0.00172	CcSEcCtD
Cabergoline—Visual impairment—Doxorubicin—sarcoma	0.00103	0.00172	CcSEcCtD
Cabergoline—Alopecia—Epirubicin—sarcoma	0.00102	0.00171	CcSEcCtD
Cabergoline—ADRA2A—lymph node—sarcoma	0.00101	0.00252	CbGeAlD
Cabergoline—Diarrhoea—Etoposide—sarcoma	0.000999	0.00167	CcSEcCtD
Cabergoline—Cardiac disorder—Doxorubicin—sarcoma	0.00099	0.00166	CcSEcCtD
Cabergoline—Flatulence—Epirubicin—sarcoma	0.000989	0.00166	CcSEcCtD
Cabergoline—Tension—Epirubicin—sarcoma	0.000984	0.00165	CcSEcCtD
Cabergoline—Nervousness—Epirubicin—sarcoma	0.000974	0.00163	CcSEcCtD
Cabergoline—Back pain—Epirubicin—sarcoma	0.00097	0.00162	CcSEcCtD
Cabergoline—Dizziness—Etoposide—sarcoma	0.000966	0.00162	CcSEcCtD
Cabergoline—Muscle spasms—Epirubicin—sarcoma	0.000965	0.00162	CcSEcCtD
Cabergoline—Arrhythmia—Doxorubicin—sarcoma	0.000953	0.0016	CcSEcCtD
Cabergoline—Alopecia—Doxorubicin—sarcoma	0.000942	0.00158	CcSEcCtD
Cabergoline—Ill-defined disorder—Epirubicin—sarcoma	0.000931	0.00156	CcSEcCtD
Cabergoline—Vomiting—Etoposide—sarcoma	0.000929	0.00156	CcSEcCtD
Cabergoline—Rash—Etoposide—sarcoma	0.000921	0.00154	CcSEcCtD
Cabergoline—Dermatitis—Etoposide—sarcoma	0.00092	0.00154	CcSEcCtD
Cabergoline—Headache—Etoposide—sarcoma	0.000915	0.00153	CcSEcCtD
Cabergoline—Flatulence—Doxorubicin—sarcoma	0.000915	0.00153	CcSEcCtD
Cabergoline—Tension—Doxorubicin—sarcoma	0.000911	0.00153	CcSEcCtD
Cabergoline—Malaise—Epirubicin—sarcoma	0.000905	0.00151	CcSEcCtD
Cabergoline—Nervousness—Doxorubicin—sarcoma	0.000902	0.00151	CcSEcCtD
Cabergoline—Vertigo—Epirubicin—sarcoma	0.000901	0.00151	CcSEcCtD
Cabergoline—Syncope—Epirubicin—sarcoma	0.0009	0.00151	CcSEcCtD
Cabergoline—Back pain—Doxorubicin—sarcoma	0.000898	0.0015	CcSEcCtD
Cabergoline—Muscle spasms—Doxorubicin—sarcoma	0.000892	0.00149	CcSEcCtD
Cabergoline—Palpitations—Epirubicin—sarcoma	0.000887	0.00148	CcSEcCtD
Cabergoline—Loss of consciousness—Epirubicin—sarcoma	0.000882	0.00148	CcSEcCtD
Cabergoline—Nausea—Etoposide—sarcoma	0.000868	0.00145	CcSEcCtD
Cabergoline—Hypertension—Epirubicin—sarcoma	0.000866	0.00145	CcSEcCtD
Cabergoline—Ill-defined disorder—Doxorubicin—sarcoma	0.000861	0.00144	CcSEcCtD
Cabergoline—Arthralgia—Epirubicin—sarcoma	0.000854	0.00143	CcSEcCtD
Cabergoline—Anxiety—Epirubicin—sarcoma	0.000851	0.00143	CcSEcCtD
Cabergoline—Discomfort—Epirubicin—sarcoma	0.000844	0.00141	CcSEcCtD
Cabergoline—Malaise—Doxorubicin—sarcoma	0.000837	0.0014	CcSEcCtD
Cabergoline—Dry mouth—Epirubicin—sarcoma	0.000835	0.0014	CcSEcCtD
Cabergoline—Vertigo—Doxorubicin—sarcoma	0.000834	0.0014	CcSEcCtD
Cabergoline—Syncope—Doxorubicin—sarcoma	0.000832	0.00139	CcSEcCtD
Cabergoline—Confusional state—Epirubicin—sarcoma	0.000826	0.00138	CcSEcCtD
Cabergoline—Palpitations—Doxorubicin—sarcoma	0.00082	0.00137	CcSEcCtD
Cabergoline—Oedema—Epirubicin—sarcoma	0.000819	0.00137	CcSEcCtD
Cabergoline—Loss of consciousness—Doxorubicin—sarcoma	0.000816	0.00137	CcSEcCtD
Cabergoline—Shock—Epirubicin—sarcoma	0.000806	0.00135	CcSEcCtD
Cabergoline—Hypertension—Doxorubicin—sarcoma	0.000801	0.00134	CcSEcCtD
Cabergoline—Hyperhidrosis—Epirubicin—sarcoma	0.000792	0.00133	CcSEcCtD
Cabergoline—Arthralgia—Doxorubicin—sarcoma	0.00079	0.00132	CcSEcCtD
Cabergoline—Anxiety—Doxorubicin—sarcoma	0.000788	0.00132	CcSEcCtD
Cabergoline—Discomfort—Doxorubicin—sarcoma	0.000781	0.00131	CcSEcCtD
Cabergoline—Anorexia—Epirubicin—sarcoma	0.00078	0.00131	CcSEcCtD
Cabergoline—Dry mouth—Doxorubicin—sarcoma	0.000773	0.00129	CcSEcCtD
Cabergoline—Hypotension—Epirubicin—sarcoma	0.000765	0.00128	CcSEcCtD
Cabergoline—Confusional state—Doxorubicin—sarcoma	0.000764	0.00128	CcSEcCtD
Cabergoline—Oedema—Doxorubicin—sarcoma	0.000758	0.00127	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000746	0.00125	CcSEcCtD
Cabergoline—Shock—Doxorubicin—sarcoma	0.000745	0.00125	CcSEcCtD
Cabergoline—Insomnia—Epirubicin—sarcoma	0.000741	0.00124	CcSEcCtD
Cabergoline—Paraesthesia—Epirubicin—sarcoma	0.000735	0.00123	CcSEcCtD
Cabergoline—Hyperhidrosis—Doxorubicin—sarcoma	0.000732	0.00123	CcSEcCtD
Cabergoline—Dyspnoea—Epirubicin—sarcoma	0.00073	0.00122	CcSEcCtD
Cabergoline—Somnolence—Epirubicin—sarcoma	0.000728	0.00122	CcSEcCtD
Cabergoline—Anorexia—Doxorubicin—sarcoma	0.000722	0.00121	CcSEcCtD
Cabergoline—Dyspepsia—Epirubicin—sarcoma	0.000721	0.00121	CcSEcCtD
Cabergoline—Decreased appetite—Epirubicin—sarcoma	0.000712	0.00119	CcSEcCtD
Cabergoline—Hypotension—Doxorubicin—sarcoma	0.000708	0.00119	CcSEcCtD
Cabergoline—Fatigue—Epirubicin—sarcoma	0.000706	0.00118	CcSEcCtD
Cabergoline—Constipation—Epirubicin—sarcoma	0.0007	0.00117	CcSEcCtD
Cabergoline—Pain—Epirubicin—sarcoma	0.0007	0.00117	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00069	0.00116	CcSEcCtD
Cabergoline—Insomnia—Doxorubicin—sarcoma	0.000685	0.00115	CcSEcCtD
Cabergoline—Paraesthesia—Doxorubicin—sarcoma	0.00068	0.00114	CcSEcCtD
Cabergoline—Dyspnoea—Doxorubicin—sarcoma	0.000675	0.00113	CcSEcCtD
Cabergoline—Feeling abnormal—Epirubicin—sarcoma	0.000675	0.00113	CcSEcCtD
Cabergoline—Somnolence—Doxorubicin—sarcoma	0.000673	0.00113	CcSEcCtD
Cabergoline—Gastrointestinal pain—Epirubicin—sarcoma	0.00067	0.00112	CcSEcCtD
Cabergoline—Dyspepsia—Doxorubicin—sarcoma	0.000667	0.00112	CcSEcCtD
Cabergoline—Decreased appetite—Doxorubicin—sarcoma	0.000659	0.0011	CcSEcCtD
Cabergoline—Fatigue—Doxorubicin—sarcoma	0.000653	0.00109	CcSEcCtD
Cabergoline—Constipation—Doxorubicin—sarcoma	0.000648	0.00108	CcSEcCtD
Cabergoline—Pain—Doxorubicin—sarcoma	0.000648	0.00108	CcSEcCtD
Cabergoline—Abdominal pain—Epirubicin—sarcoma	0.000647	0.00108	CcSEcCtD
Cabergoline—Feeling abnormal—Doxorubicin—sarcoma	0.000624	0.00105	CcSEcCtD
Cabergoline—Gastrointestinal pain—Doxorubicin—sarcoma	0.000619	0.00104	CcSEcCtD
Cabergoline—Hypersensitivity—Epirubicin—sarcoma	0.000603	0.00101	CcSEcCtD
Cabergoline—Abdominal pain—Doxorubicin—sarcoma	0.000599	0.001	CcSEcCtD
Cabergoline—Asthenia—Epirubicin—sarcoma	0.000587	0.000984	CcSEcCtD
Cabergoline—Pruritus—Epirubicin—sarcoma	0.000579	0.00097	CcSEcCtD
Cabergoline—Diarrhoea—Epirubicin—sarcoma	0.00056	0.000938	CcSEcCtD
Cabergoline—Hypersensitivity—Doxorubicin—sarcoma	0.000558	0.000935	CcSEcCtD
Cabergoline—Asthenia—Doxorubicin—sarcoma	0.000544	0.00091	CcSEcCtD
Cabergoline—Dizziness—Epirubicin—sarcoma	0.000541	0.000907	CcSEcCtD
Cabergoline—Pruritus—Doxorubicin—sarcoma	0.000536	0.000898	CcSEcCtD
Cabergoline—Vomiting—Epirubicin—sarcoma	0.000521	0.000872	CcSEcCtD
Cabergoline—Diarrhoea—Doxorubicin—sarcoma	0.000518	0.000868	CcSEcCtD
Cabergoline—Rash—Epirubicin—sarcoma	0.000516	0.000864	CcSEcCtD
Cabergoline—Dermatitis—Epirubicin—sarcoma	0.000516	0.000864	CcSEcCtD
Cabergoline—Headache—Epirubicin—sarcoma	0.000513	0.000859	CcSEcCtD
Cabergoline—Dizziness—Doxorubicin—sarcoma	0.000501	0.000839	CcSEcCtD
Cabergoline—Nausea—Epirubicin—sarcoma	0.000486	0.000814	CcSEcCtD
Cabergoline—Vomiting—Doxorubicin—sarcoma	0.000482	0.000807	CcSEcCtD
Cabergoline—Rash—Doxorubicin—sarcoma	0.000478	0.0008	CcSEcCtD
Cabergoline—Dermatitis—Doxorubicin—sarcoma	0.000477	0.000799	CcSEcCtD
Cabergoline—Headache—Doxorubicin—sarcoma	0.000475	0.000795	CcSEcCtD
Cabergoline—Nausea—Doxorubicin—sarcoma	0.00045	0.000754	CcSEcCtD
